Cargando…
rhIGF-1/rhIGFBP-3 in Preterm Infants: A Phase 2 Randomized Controlled Trial
OBJECTIVE: To investigate recombinant human insulin-like growth factor 1 complexed with its binding protein (rhIGF-1/rhIGFBP-3) for the prevention of retinopathy of prematurity (ROP) and other complications of prematurity among extremely preterm infants. STUDY DESIGN: This phase 2 trial was conducte...
Autores principales: | Ley, David, Hallberg, Boubou, Hansen-Pupp, Ingrid, Dani, Carlo, Ramenghi, Luca A., Marlow, Neil, Beardsall, Kathryn, Bhatti, Faizah, Dunger, David, Higginson, Jason D., Mahaveer, Ajit, Mezu-Ndubuisi, Olachi J., Reynolds, Peter, Giannantonio, Carmen, van Weissenbruch, Mirjam, Barton, Norman, Tocoian, Adina, Hamdani, Mohamed, Jochim, Emily, Mangili, Alexandra, Chung, Jou-Ku, Turner, Mark A., Smith, Lois E. H., Hellström, Ann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389415/ https://www.ncbi.nlm.nih.gov/pubmed/30471715 http://dx.doi.org/10.1016/j.jpeds.2018.10.033 |
Ejemplares similares
-
Randomized Control Trial of Postnatal rhIGF-1/rhIGFBP-3 Replacement in Preterm Infants: Post-hoc Analysis of Its Effect on Brain Injury
por: Horsch, Sandra, et al.
Publicado: (2020) -
Assessment of compatibility of rhIGF-1/rhIGFBP-3 with neonatal intravenous medications
por: Salamat-Miller, Nazila, et al.
Publicado: (2022) -
Pilot dose-ranging of rhIGF-1/rhIGFBP-3 in a preterm lamb model of evolving bronchopulmonary dysplasia
por: Albertine, Kurt H., et al.
Publicado: (2023) -
rhIGF-1 Therapy: A Silver Bullet for Bronchopulmonary Dysplasia
Prevention?
por: Plosa, Erin J., et al.
Publicado: (2020) -
Effectiveness and safety of rhIGF1 therapy in patients with or without Laron syndrome
por: Bang, Peter, et al.
Publicado: (2020)